Get more replies from employers
Send a job-specific resume in minutes.
Otsuka Pharmaceutical Co., Ltd. seeks a senior analytical leader to oversee strategy and technical analytics across third party labs. The role drives method development, validation, and transfer for small molecules and peptides, ensuring GMP/GxP compliance and alignment with regulatory expectations.
You will collaborate across regulatory affairs, QA, and development teams to resolve complex issues, mentor staff, and deliver scientific insights that advance IND/NDAs and clinical milestones.
This role provides strategy and technical expertise to oversee analytical activities at third party laboratories, including method development/validation/qualification, stability testing, and investigational testing. In addition, there is responsibility to provide regulatory support from early phase drug development to commercial with technical aspects by developing analytical tools to gain understanding of key quality attributes in product and process for early to late phase synthetic small molecule, synthetic peptide, and/or other modalities. Collaborate cross-functionally with analytical team members, drug substance and drug product process development colleagues, regulatory affairs, quality assurance, and other departments to drive scientific excellence, resolve complex technical issues, and ensure compliance with applicable regulations and guidelines while maintaining alliance with internal timelines and corporate/project goals. Lead analytical activities such as method development, optimization and transfer for synthetic small molecules testing and characterization at CMO or contract testing labs. Provide actionable insights and recommendations to optimize project outputs for the project teams based on holistic analysis of the analytical projects including logistics, budgeting, method development through release testing and reporting. Monitor progress, identify potential risks, implement appropriate mitigation strategies, and ensure alignment with the strategic objectives. Lead the development and implementation of scientific strategies, ensuring alignment with regulatory requirements and industry best practices in the pharmaceutical field. Provide analytical data to support drug substance and drug product development, including purity analysis, chiral purity, and structure elucidation using mass spectrometry. Manage pharmaceutical stability studies, including protocols and timelines, for investigational new drug (IND) and new drug application (NDA) activities, ensuring compliance with regulatory guidelines and industry standards. Author technical reports and Chemistry, Manufacturing, and Controls (CMC) sections in regulatory documents. Mentor and train team members, fostering their professional growth and expertise in pharmaceutical analytical testing.
Minimum $134,615.00 - Maximum $201,250.00, plus incentive opportunity: The range shown represents a typical pay range or starting pay for individuals who are hired in the role to perform in the United States. Other elements may be used to determine actual pay such as the candidate’s job experience, specific skills, and comparison to internal incumbents currently in role. Typically, actual pay will be positioned within the established range, rather than at its minimum or maximum. This information is provided to applicants in accordance with states and local laws.
Otsuka is an equal opportunity employer. All qualified applicants are encouraged to apply and will be given consideration for employment without regard to race, color, sex, gender identity or gender expression, sexual orientation, age, disability, religion, national origin, veteran status, marital status, or any other legally protected characteristic.
Otsuka is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” In the U.S., Otsuka is comprised of two companies, Otsuka America Pharmaceutical, Inc., and Otsuka Pharmaceutical Development & Commercialization, Inc., that share a deep commitment to the development and commercialization of innovative products in the spaces of neuroscience, nephrology, and digital medicine. Driven by our purpose to defy limitation, so that others can too, we have an unwavering belief in doing more and transcending expectations. In going above and beyond—under any circumstances—for patients, families, providers, and for each other. It’s this deep-rooted dedication that drives us to uncover answers to complex, underserved medical needs, so that patients can push past the limitations of their disease and achieve more than they thought was possible each and every day. OPDC and OAPI are indirect subsidiaries of Otsuka Pharmaceutical Company, Ltd., which is a subsidiary of Otsuka Holdings Co., Ltd. headquartered in Tokyo, Japan. The Otsuka group of companies employed 34,400 people worldwide and had consolidated sales of approximately USD 14.2 billion in 2023. We invite you to explore our open positions for an opportunity to join our 2,200 colleagues in the U.S. whose passion for our mission and pride in our company have earned us certification as a Great Place to Work by the Great Place to Work Institute.